To establish further a practical quantitative in chemico reactivity assay for screening contact allergens, lysine peptide was incorporated into a liquid chromatography and tandem mass spectrometry-based assay for reactivity assessments of hapten and pre-/pro-hapten chemical sensitizers. Loss of peptide was determined following 24 h coincubation with test chemical using a concentration-response study design. A total of 70 chemicals were tested in discrete reactions with cysteine or lysine peptide, in the presence and absence of horseradish peroxidase-hydrogen peroxide oxidation system. An empirically derived prediction model for discriminating sensitizers from nonsensitizers resulted in an accuracy of 83% for 26 haptens, 19 pre-/pro-haptens, and 25 nonsensitizers. Four sensitizers were shown to selectively react with lysine including two strong/extreme and two weak sensitizers. In addition, seven sensitizers were identified as having higher reactivity toward lysine compared with cysteine. The majority of sensitizing chemicals (27/45) were reactive toward both cysteine and lysine peptides. An estimate of the relative reactivity potency was determined based on the concentration of test chemical that depletes peptide at or above a threshold positive value. Here, we report the use of EC15 as one example to illustrate the use of the model for screening the skin sensitization potential of novel chemicals. Results from this initial assessment highlight the utility of lysine for assessing a chemical's potential to elicit sensitization reactions or induce hypersensitivity. This approach has the potential to qualitatively and quantitatively evaluate an important mechanism in contact allergy for hazard and quantitative risk assessments without animal testing.
To establish further a practical quantitative in chemico reactivity assay for screening contact allergens, lysine peptide was incorporated into a liquid chromatography and tandem mass spectrometry-based assay for reactivity assessments of hapten and pre-/pro-hapten chemical sensitizers. Loss of peptide was determined following 24 h coincubation with test chemical using a concentration-response study design. A total of 70 chemicals were tested in discrete reactions with cysteine or lysine peptide, in the presence and absence of horseradish peroxidase-hydrogen peroxide oxidation system. An empirically derived prediction model for discriminating sensitizers from nonsensitizers resulted in an accuracy of 83% for 26 haptens, 19 pre-/pro-haptens, and 25 nonsensitizers. Four sensitizers were shown to selectively react with lysine including two strong/extreme and two weak sensitizers. In addition, seven sensitizers were identified as having higher reactivity toward lysine compared with cysteine. The majority of sensitizing chemicals (27/45) were reactive toward both cysteine and lysine peptides. An estimate of the relative reactivity potency was determined based on the concentration of test chemical that depletes peptide at or above a threshold positive value. Here, we report the use of EC15 as one example to illustrate the use of the model for screening the skin sensitization potential of novel chemicals. Results from this initial assessment highlight the utility of lysine for assessing a chemical's potential to elicit sensitization reactions or induce hypersensitivity. This approach has the potential to qualitatively and quantitatively evaluate an important mechanism in contact allergy for hazard and quantitative risk assessments without animal testing.
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Allergic contact dermatitis (ACD) is the clinical manifestation of skin sensitization and an important toxicological endpoint for occupational and consumer health risk assessments. In vivo models for evaluating the potential of novel materials to act as skin allergens are used routinely and globally accepted for use in identifying hazard. Based on the murine Local Lymph Node Assay (LLNA), both hazard and potency information are used for quantitative risk assessments via determination of the concentration that produces a threshold positive response and classification of the relative skin sensitizing potency Dearman et al., 1999; Gerberick et al., 2000; Kimber et al., 1994 Kimber et al., , 2002 . The forthcoming ban on animal testing of cosmetic and toiletry ingredients in Western Europe will essentially make in vivo models obsolete, however, and require the cosmetic industry to rely solely on alternatives for assessing risk in contact allergy. Non-animal-based prediction models have therefore been a major focus of the toxicological community for more than a decade.
The ability of a chemical to react with skin proteins is thought to play a key role in the development of skin sensitization (Dupuis and Benezra, 1982; Gerberick et al., 2008; Landsteiner and Jacobs, 1936; Lepoittevin et al., 1998) . Contact allergens are generally low molecular weight molecules that have the ability to penetrate the stratum corneum and covalently modify skin proteins through a variety of reactivity mechanisms. Reaction products are immunogenic and stimulate the migration and maturation of Langerhans cells from the epidermis to local skin-draining lymph nodes for antigen presentation to naive T cells, resulting in the clonal expansion of antigen-specific memory T cells (Ryan et al., 2001) .
Sensitizers (or their metabolites) are generally electrophilic and reactive toward nucleophilic sites on proteins. This feature has been exploited by investigators that are interested in developing non-animal approaches for evaluating the skin sensitization potential of novel materials based on reactivity with nucleophile-containing peptides. Although there are other nucleophilic amino acids, the e-NH 2 group of lysine and the -SH group of cysteine are relatively strong nucleophiles and often cited in the literature for assessing hapten reactivity (Ahlfors et al., 2003; Alvarez-Sanchez et al., 2003; Dupuis and Benezra, 1982; Lepoittevin et al., 1998; Meschkat et al., 2001) .
In the Direct Peptide Reactivity Assay (DPRA), peptide depletion at a single peptide and test chemical concentration following 24 h coincubation is determined (Gerberick et al., 2004) . A prediction accuracy of 89% was demonstrated with a data set that included 82 chemicals . Some sensitizers are nonelectrophilic and require activation to protein reactive intermediates (Gerberick et al., 2009; Lepoittevin, 2006; Smith and Hotchkiss, 2001) . To expand the applicability domain of the DPRA, designed specifically for directly reactive haptens, we recently reported the development of a modified version with horseradish peroxidase-hydrogen peroxide (HRP/P) for the enzymatic activation of pro-hapten sensitizers with cysteine (Gerberick et al., 2009) . Although thiol reactivity is very important, other nucleophiles could be useful for identifying sensitizers that are less promiscuous and preferentially react to specific amino acids other than cysteine.
Reactivity with lysine has been suggested as an important mechanism for generating modified protein targets in ACD (Alvarez-Sanchez et al., 2003 , Eilstein et al., 2008 , Gerberick et al., 2004 . Although many chemical sensitizers are highly reactive toward thiol-containing molecules, formation of antigenic structures resulting from lysine reactivity may have synergistic effects on the amount and diversity of modified protein products. In addition, haptens covalently linked to lysine residues have been shown to play a role in MHC recognition and activation of T lymphocytes (Weltzien et al., 1996) . Characterizing the potential for chemical-induced modification of lysine in chemico may contribute to the development of an integrated testing strategy for risk assessments.
In this report, we describe the incorporation of lysine peptide into the Peroxidase Peptide Reactivity Assay (PPRA). Discrete reactivity determinations for cysteine and lysine ± HRP/P are used to assess peptide reactivity of hapten and pre-/pro-hapten sensitizers. The assay utilizes high performance liquid chromatography and tandem mass spectrometry (HPLC/MS/MS) detection for monitoring peptide disappearance following 24 h coincubation with test chemicals. In addition, peptide reactivity is characterized using a concentration-response study design such that the concentration that depletes peptide by 15% (EC15) is determined. Reactivity of 25 nonsensitizers, 26 haptens and 19 pre-/pro-haptens of diverse chemical structure and sensitization potency were examined. The PPRA screening approach described here has the potential to contribute to a more comprehensive assessment of skin sensitization potential of all possible allergens (i.e., haptens, pre-haptens, and pro-haptens). [122-40-7] ; b-propriolactone, ! 90% [57-57-8] . Desferroxamine (catalog number D9533), horseradish peroxidase (catalog number P6140), hydrogen peroxide (catalog number 216763), and DL-dithiothreitol (catalog number D5545-16) were purchased from Aldrich Chemical Company. The cysteine peptide (Ac-RFAACAA-COOH) and lysine peptide (Ac-RFAAKAA-COOH) were prepared and purified by the SynBioSci (Livermore, CA). Leucine enkephalin internal standard (catalog number L9133) was purchased from Sigma Aldrich Chemical Company (St Louis, MO) . N a -acetyl-leucine enkephalin internal standard was purchased from RS Synthesis (Louisville, KY).
MATERIALS AND METHODS
Direct lysine-and cysteine-peptide incubation conditions. Direct reactivity of test chemical to lysine-based synthetic peptide was determined in reactions containing 0.1 M ammonium acetate buffer (pH 10.2). Unless otherwise indicated, the final concentration of lysine peptide was 5lM in a final reaction volume of 0.3 ml. Direct reactivity of test chemicals to cysteine-based synthetic peptide was determined as previously described (Gerberick et al., 2009) . Incubations with lysine or cysteine peptide and no test chemical, in the absence of HRP/P, served as zero-depletion reference controls for comparisons to direct reactivity determinations. Sample reactions were initiated by adding 3 ll of a test chemical stock solution. The final organic content in each reaction was 1%. Samples were incubated under ambient laboratory conditions for 24 h.
Peptide incubation with HRP/P. Enzyme-mediated reactivity determinations were performed in sample reactions that were prepared as described above, but with addition of horseradish peroxidase and hydrogen peroxide (HRP/P) at a final concentration of 3 U/ml and 100lM, respectively.
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Incubations with either lysine or cysteine peptide and no test chemical, in the presence of HRP/P, served as zero-depletion reference controls for comparisons to enzyme-mediated test chemical reactivity determinations.
HRP activity characterization using pyrogallol. Enzymatic activity of horseradish peroxidase (HRP) was determined spectrophotometrically by measuring (at 420 nm) the formation rate of purpurogallin from pyrogallol. Sample reactions were initiated by addition of HRP (0.0035 units) to individual wells of a microtiter plate containing potassium phosphate buffer (0.1 M, pH 7.4 and 10), hydrogen peroxide (0.027%, vol/vol), and pyrogallol (0.525%, wt/ vol). Incubations were performed in triplicate at a final reaction volume of 0.2 ml. Sample reactions without HRP served as blanks and were used to subtract background absorbance. The change in optical density was recorded at 20-s intervals at 420 nm for 5 min (i.e., the linear portion of the kinetic curve) using a SpectraMax M5 (Molecular Devices) microplate reader. The extinction coefficient of 1 mg/ml of purpurogallin is 12 as reported by the supplier of the compound standard.
Sample processing and analysis by HPLC/MS/MS. Following the incubation period, samples were diluted with 0.3 ml of internal standard solution (3 lg/ml N a -acetyl-leucine enkephalin in 95:5 acetonitrile:water), and 20 ll of each sample was diluted with 780 ll of 2:98 acetonitrile:water. In sample reactions containing cysteine, a 20 ll aliquot of a 16mM dithiothreitol solution (prepared in water) was then added, and samples were heated in a 45°C oven for 30 min, then allowed to cool to room temperature prior to analysis.
Analysis was primarily designed to selectively monitor two analytes: the cysteine peptide (monomer) and N a -acetyl-leucine enkephalin internal standard (IS), and in a separate method, the lysine peptide and IS. The HPLC/MS/MS methodology employed a CTC HTS-PAL autosampler (Leap Technologies, Carrboro, NC) for sample introduction. Chromatographic separation was carried out using a 10ADvp pumping system (Shimadzu, Colombia, MD). Injection volumes of 20 ll were made onto a Gemini-NX C18 (2.1 3 20 mm, 3 lm) analytical column (Phenomenex, Torrance, CA). The mobile phase, at a flow rate of 0.7 ml/min, consisted of water with 1mM ammonium bicarbonate (A) and 99:1 methanol:water, 1mM ammonium bicarbonate (B). Separation was achieved by holding at initial conditions (99% A) for 1 min, then a 1.0 min linear gradient to 100% B for 1 min, and then step down to initial conditions for a total analysis time of 6 min per sample.
The chromatographic effluent is interfaced to a Sciex API 3000 triple quadrupole mass spectrometer (Applies Biosystems, Foster City, CA), equipped with TurboIonSpray and operated in positive electrospray ionization mode. To achieve high selectivity and sensitivity, the following selected reaction monitoring (SRM) schemes were optimized for detection: cysteine (m/ z 751-to-120), lysine (m/z 389-to-129), and N a -acetyl leucine enkephalin IS (m/z 598-to-120). Note that for cysteine and IS, MH þ is monitored, whereas
[Mþ2H] 2þ is monitored for lysine. In addition, the thiol-dimer form of the cysteine peptide was chromatographically resolved from and monitored in the SRM channel of the targeted monomer (due to its [M#þ2H] 2þ form). For typical batch analyses, the cysteine samples are analyzed first to minimize the potential for subsequent dimer formation, followed by the lysine samples. For batches involving multiple test compounds, the direct and enzyme-mediated reactivity sample sets were analyzed in alternating fashion, and each of the test chemical sample sets were bracketed by a pair of the respective zero-depletion control samples. This allowed for a more precise comparison of reactivity between direct and enzyme-mediated conditions for each test compound. Also, by using the mean of the two bracketing control sample results (i.e., analyzed in closest temporal proximity to the test samples) optimal accuracy in depletion measurement was achieved.
Data reduction for peptide depletion measurements. SRM peak areas and area ratios (cysteine or lysine peptide-to-internal standard) were determined for each sample, using the Sciex Analyst 1.4.1 quantitation software package. Peptide depletion in samples with test chemical was calculated by comparing the peak area or peak area ratio in samples containing test chemical to the average of the peak area ratio that was calculated from the corresponding pair of bracketing control samples. In sample reactions that were evaluated in replicates, peptide depletion values for individual replicates were determined and then used to calculate mean (N ¼ 2) or mean and SD (N ¼ 3) for both the direct (no HRP/P) and enzyme-mediated (with HRP/P) reactivity determinations. During preliminary method development work, loss of signal for the leucine enkephalin internal standard (LE IS) was observed for certain chemicals (data not shown). These results indicated an apparent reactivity between the test chemical and the internal standard, which later led to the replacement of LE IS with the current N a -acetyl-leucine enkephalin as part of the final methodology.
EC15 Estimation. Peptide reactivity, expressed in terms of EC15, is an estimate of the test chemical concentration that depletes the peptide by 15% under the experimental conditions described above. EC15 values were determined by fitting a three-parameter log-logistic model to peptide depletion data using RExcel (www.statconn.com). Prior to analysis, all negative depletion values were set to zero. Reactivity was reported as ''NC'' (not calculated) if depletion at all concentrations were at or below threshold values of 10% for cysteine without HRP/P, 40% for cysteine with HRP/P, and 15% for lysine with or without HRP/P. These cutoff values were determined empirically (as described in the ''Discussion'' section) based on direct observation of overall trends in reactivity for sensitizers and nonsensitizers with and without HRP/P. If peptide depletion was threshold positive but low or insufficient for estimating the EC15 (i.e., no concentration-response), reactivity was designated as NR (not reported). For Cooper statistics, test chemicals that were not threshold positive (i.e., NC) were considered nonsensitizers and those with EC15 values or designated as ''NR'' were considered sensitizers.
RESULTS

Recovery of Lysine Peptide following Incubation with and without HRP/P
Prior to performing experiments with chemical sensitizers, a preliminary study was conducted to monitor the selective loss of lysine peptide by HPLC/MS/MS, following incubation in the presence and absence of HRP (3 U/ml) and hydrogen peroxide (100lM). Sample reactions were performed in triplicate as described above. In comparison to reactions that were quenched immediately following addition of lysine (5lM), mean (± SD) depletion of lysine at 2 h was 7.6 ± 1.9% (without HRP/P) and À3.1 ± 5.9% (with HRP/P). Following 24 h incubation, mean lysine depletion was 6.4 ± 4.9% (without HRP/P) and 7.6 ± 2.5% (with HRP/P). These findings suggest essentially complete recovery of lysine peptide in reactions with and without HRP/P and substantiate their use as zero-depletion reference controls for calculating lysine peptide depletion in reactions containing test chemical.
HRP Activity Determinations as a Function of pH
To ensure adequate enzymatic activity of HRP at pH 10, formation of purpurogallin from the HRP substrate pyrogallol was evaluated at pH 7.4 and 10. Mean HRP activity at pH 7.4 and 10 was 0.133 (3.0 % coefficient of variation [CV] ) and 0.130 (2.0 %CV) U/ml of enzyme, respectively, indicating no significant differences in HRP activity were observed. This finding has significance for identifying potential lysine-reactive pro-haptens in the presence of the HRP/P oxidation system. The e-amino group of lysine has a pKa of 10.5. Lysine peptide 424 reactions are performed at pH 10 to ensure that the amine is sufficiently deprotonated and available for reactivity.
Test Chemical Concentration-Dependency in Direct Lysine
Peptide Reactivity
Direct lysine peptide reactivity with p-benzoquinone was determined at initial peptide concentrations of 0.005, 0.05, and 0.5mM in triplicate reactions containing 25% acetonitrile (ACN). For each peptide concentration examined, p-benzoquinone was coincubated at a final concentration of 0.25, 2.5, and 25mM in a final reaction volume of 0.3 ml. Following 24 h incubation, sample reactions at initial lysine peptide concentrations of 0.05 and 0.5mM were diluted 1:9 and 1:99, respectively, in 0.1 M ammonium acetate buffer (pH 10.2) containing 25% ACN. The samples were then processed along with the 0.005mM lysine peptide incubates and analyzed by liquid chromatography and tandem mass spectrometry (LC/MS/MS) as described in the ''Materials and Methods'' section. At concentrations of 0.25, 2.5, and 25mM p-benzoquinone, direct lysine peptide depletion was approximately 15, 50, and 85%, respectively, and appeared to be independent of the initial concentration of lysine peptide and corresponding peptide: chemical molar ratio (Fig. 1A) .
To directly compare depletion data from this modified LC/ MS/MS-based reactivity assessment to historical values from the LC/UV-based DPRA method, a set of control reactions were prepared according to Gerberick et al. (2004) . Briefly, triplicate reactions were prepared with a 1.0 ml reaction volume containing lysine peptide (0.5mM) and p-benzoquinone (25mM) in clear glass. Immediately following addition of test chemical, a 0.3 ml aliquot was removed from each replicate and transferred to individual wells of a 96-well plate. The samples were then incubated for 24 h under ambient laboratory conditions. As shown in Figure 1B , peptide reactivity in these split samples that were either incubated in glass or plastic were equally high (85% depletion) and consistent with those in Figure 1A at the 25mM test chemical concentration. Depletion of lysine peptide in reactions with p-benzoquinone corroborates DPRA depletion data (Gerberick et al., 2004) and supports the use of LC/MS/MS as an appropriate detection method for peptide reactivity assessments.
To demonstrate that the initial study results with p-benzoquinone were reproducible and to determine whether similar trends would be observed with other known lysinereactive sensitizers, the experiment was repeated with p-benzoquinone, 3-methylcatechol, and glutaraldehyde. Sample conditions were identical to those described above except for the concentration of glutaraldehyde, which was tested at final concentrations of 0.125, 1.25, and 12.5mM. Due to the differential loss in signal of the nonacetylated internal standard (LE IS) for certain test chemical incubations, at the higher concentrations (data not shown), peptide depletion for this data set was calculated using lysine peptide peak area values rather than peak area ratios. As shown in Table 1 , trends in reactivity were consistent with previous findings with p-benzoquinone. For 3-methylcatechol and glutaraldehyde, reactivity also appeared to be test chemical concentration dependent with maximum depletion values being observed at the highest concentrations tested, regardless of the initial concentration of peptide. Comparisons between each of the three peptide concentrations at each test chemical concentration showed that the highest depletion value typically corresponded to reactions containing either 0.005 or 0.05mM lysine peptide. Based on these findings, the concentration of lysine peptide chosen for subsequent method development was 0.005mM.
FIG. 1.
Direct lysine peptide reactivity with p-benzoquinone at peptide and chemical concentrations of (A) 0.005, 0.05, and 0.5mM and 0.25, 2.5, and 25mM, respectively. Incubations were performed in a 96-well plate at a final reaction volume of 0.3 ml (in triplicate). (B) Comparator reactions were prepared in glass (in triplicate) to mimic incubation conditions in the DPRA (i.e., final reaction volume of 1.0 ml at peptide and chemical concentrations of 0.5mM and 25mM, respectively). Immediately following addition of test chemical to these samples, an aliquot of the reaction was transferred to a 96-well plate (in plastic) and incubated for 24 h. The figures show the percentage of lysine peptide depletion, expressed in terms of mean (±SD) of triplicate incubations.
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Concentration-Response Studies in Direct Lysine Peptide
Reactivity Determinations Concentration-response studies were conducted to characterize direct reactivity profiles for 10 chemicals at final test chemical concentrations ranging from 0.008 to 25mM in duplicate reactions containing 1% organic. Test chemicals were selected based upon historical lysine reactivity data in the DPRA and represent low, moderate, and high reactivity categories. As shown in Figure 2 , direct lysine peptide depletion generally increased with an increase in test chemical concentration for p-benzoquinone, glutaraldehyde, 3,4-dihydrocoumarin, 3-methylcatechol, and propyl gallate, all of which exhibited relatively high reactivity toward lysine. Although depletion increased with an increase in concentration for oxazolone, reactivity was generally low with approximately 20% depletion being observed at the two highest concentrations tested. Reactivity between lysine and cinnamaldehyde or 2-phenylpropionaldehyde was negligible at all concentrations tested except at 25mM in which~25% depletion was observed. Citral and n-hexane reactivity toward lysine under direct (ÀHRP/P) conditions was low/negligible.
In an effort to enhance lysine peptide reactivity and to minimize the need for testing at relatively high (and often solubility limiting) test chemical concentrations, the effect of incubation temperature on direct peptide depletion was examined following 24 h incubation. Incubations were performed under ambient laboratory conditions or in a water bath at 30°C. As shown in Figure 3 , no significant increase in depletion was noted for p-benzoquinone and 3-methylcatechol at elevated temperature. Only subtle increases in depletion were observed for a-methyl cinnamaldehyde and glutaraldehyde, which may be attributed to an increase in the rate of reaction and/or solubility of the test chemical. The finding that incubation temperature had little effect on depletion is highly unusual and suggests that the reactions have already gone to completion prior to the 24 h time point. Due to the lack of significant increases in depletion following 24 h incubation at higher temperature, sample reactions in subsequent studies were performed under ambient laboratory conditions.
Concentration-Response Testing with Lysine and Cysteine
Peptides ± HRP/P Concentration-response studies were conducted to characterize reactivity profiles for an expanded set of chemical allergens and nonallergens. Final test chemical concentrations were targeted at 0.003, 0.03, 0.3, 3, and 30mM in reactions containing lysine (5lM) or cysteine (20lM) peptides in the Table 2 . Peptide depletion data for pre-haptens and pro-haptens are presented in Table 3 . The chemicals are listed according to sensitization category (as defined by published LLNA data) to facilitate better comparisons of peptide depletion across categories.
Peptide Depletion Results for Haptens, Pre-haptens, Pro-haptens, and Nonsensitizers
As shown in Table 2 , peptide depletion for the majority of hapten chemical sensitizers was > 10% for cysteine and > 15% for lysine. With exception to methyl acrylate and ethyl acrylate, maximum peptide depletion for weak haptens generally ranged from 20 to 40% for cysteine and 20 to 50% for lysine. Maximum depletion values for moderate, strong, and extreme haptens typically ranged from 30 to 100% for cysteine or lysine peptides. Hapten chemical allergens that showed little to no reactivity toward both peptides were a-methyl cinnamaldehyde, hexyl cinnamaldehyde, and phenylacetaldehyde. In contrast, peptide depletion in the absence of HRP/P for the majority of nonsensitizers did not exceed 10% for cysteine and 15% for lysine. In the presence of HRP/P, peptide depletion was similarly 
a Reactivity was determined following 24 h incubation under ambient conditions in reactions containing cysteine (20lM) or lysine (5lM) peptide in the presence and absence of HRP (3.0 U/ml) and hydrogen peroxide (100lM) in 0.1 M potassium phosphate buffer (pH 7.4) or 0.1 M ammonium acetate buffer (pH 10.2), respectively. LLNA potency data were from Gerberick et al., (2005) , except for 3-methylcatechol (Unilever, unpublished data). NS ¼ nonsensitizer. NC, not calculated; ND, Not determined. Conc  C1  C2  C3  C4  C5  C1  C2  C3  C4  C5  C1 C2  C3  C4  C5  C1  C2  C3  C4 
low except for a few nonsensitizers that showed > 10% depletion at the 30mM test chemical concentration with cysteine. 4-Hydroxybenzoic acid, methyl paraben, and propyl paraben were reactive at lower concentrations with cysteine þ HRP/P but depletion profiles generally lacked a concentration response.
Enzyme-mediated activation of pro-haptens resulted in an increase in depletion with cysteine and HRP/P with maximum depletion values ranging from 20% to nearly 100% (Table 3) . With exception to 5-amino-2-methylphenol, 1-naphthol, and lauryl gallate, no apparent reactivity was observed for prohaptens with lysine and HRP/P. For pre-haptens, subtle differences in cysteine depletion were observed in the presence and absence of HRP/P. Hydroquinone and 3-methylcatechol were the only pre-haptens that reacted with lysine-containing peptide.
Cooper statistics were calculated to compare reactivity results from this screening assay to hazard information obtained in the LLNA. Test chemicals were classified empirically as positive (sensitizers) if depletion at any test chemical concentration was > 10% for cysteine without HRP/P, > 40% for cysteine with HRP/P, or > 15% for lysine with or without HRP/P. The test chemicals that did not meet these criteria were classified as nonsensitizers. As shown in Table 4 , the accuracy, or proportion of true sensitizers and nonsensitizers predicted correctly, was 83%. Values for sensitivity and specificity were 93 and 64%, indicating the proportion of all correctly identified sensitizers and nonsensitizers, respectively. Positive predictivity (the proportion of chemicals positive in the PPRA that are sensitizers in the LLNA) was 82%, and negative predictivity (the proportion of chemicals negative in the PPRA that are nonsensitizers in the LLNA) was 84%.
Finally, the estimated test chemical concentration that depletes peptide by 15% (EC15) was determined for peptidereactive chemicals that showed a concentration-response. Test materials that were reactive but did not show a reasonable concentration-response for deriving an EC15 were designated as NR (not reported) but considered positive (for Cooper statistics). These data are presented in Table 5 along with the nucleophile and reaction condition (± HRP/P) corresponding to the overall lowest EC15. Median EC15 values for each category, excluding outliers, were 4.5mM (nonsensitizers), 0.55mM (weak), 0.042mM (moderate), and 0.030mM (strong/ extreme). Figure 4 presents these data graphically to illustrate the distribution of peptide reactivity for each sensitization category.
DISCUSSION
Advancements in understanding the pathogenesis of ACD have challenged investigators to develop and refine hypothesisdriven alternatives to ultimately inform whether a chemical has the potential to act as a contact allergen in the absence of in vivo data. Unlike rodent models which are intact dynamic systems and possess many important anatomical and physiological features that are similar to those in human, alternative approaches are relatively static and focus on characterizing discrete cellular, biochemical, and/or chemical events for subsequent use in developing risk assessment paradigms. Although the relative importance of each test and the specifics on how the data will ultimately be integrated into a quantitative risk assessment is under evaluation, it is generally accepted that in order for a chemical to cause skin sensitization, it must react with protein within the viable epidermis to form a complete antigen. Because protein reactivity is a key step in the induction of ACD, investigators have reported the use of a number of model nucleophiles in an effort to develop in chemico approaches for predicting the skin sensitization potential of new chemicals based on reactivity. Published reports have included the use of synthetic peptides containing single or multiple nucleophilic amino acids, glutathione, human serum albumin, and 4-nitrobenzenethiol (Aleksic et al., 2009; Alvarez-Sanchez et al., 2004a , 2004b Aptula et al., 2006; Chipinda et al., 2010; Enoch et al., 2009; Gerberick et al., 2004 Gerberick et al., , 2007 Gerberick et al., , 2008 Kato et al., 2003; Natsch et al., 2007; Natsch and Gfeller, 2008; Roberts and Natsch, 2009; Schultz et al., 2005) .
As the majority of model nucleophiles are thiol based, it is essential to also develop methods that allow for routine reactivity determinations with other nucleophiles, particularly those that have been shown to form antigenic products. It has been hypothesized that the immunogenicity of contact allergens is directly related to their ability to modify a few specific amino acids (Alvarez-Sanchez et al., 2003; Eilstein et al., 2008; Meschkat et al., 2001) . Lysine is clearly an important amino acid and a good representative of hard nucleophiles that are expected to selectively react with hard electrophiles (Gerberick et al., 2004) . In addition to reactivity with soft nucleophiles such as cysteine or tyrosine, the diversity of hapten-protein interactions and the selective modification of lysine residues have been demonstrated with 5-chloro-2-methylisothiazol-3-one (MCI) and Note. Table statistics for the shadowed 2 3 2 table: sensitivity: 93%; specificity: 64%; positive predictivity: 82%; negative predictivity: 84%; accuracy: 83%. a Test chemicals with depletion > 10% for cysteine (ÀHRP/P), > 40% for cysteine (þ HRP/P), > 15% for lysine (ÀHRP/P) or > 15% for lysine (± HRP/ P) were classified as sensitizers. Eilstein et al., 2008; Meschkat et al., 2001) . Reactivity in the DPRA further supports the utility for measuring lysine reactivity, particularly for identifying extreme and strong chemical allergens (Gerberick et al., 2004 .
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To establish further a practical quantitative in chemico peptide-based reactivity assay for screening contact allergens in our laboratory, we have recently completed the initial work of incorporating lysine peptide into an LC/MS/MS-based assay for discrete reactivity assessments of hapten, prehapten, and pro-hapten chemical sensitizers. The approach is based on a refined version of the DPRA in which loss of peptide is determined following 24 h coincubation with test chemical under ambient laboratory conditions in the presence and absence of horseradish peroxidase-hydrogen peroxide (HRP/P) oxidation system. The DPRA, which is currently in phase III pre-validation by the European Centre for the Validation of Alternative Methods (ECVAM), has demonstrated a strong correlation between in chemico reactivity of hapten chemical sensitizers to both a cysteine-or lysinecontaining synthetic peptide and skin sensitization potential. A next generation assay was developed to include an activation step using a peroxidase-peroxide oxidation system for identifying potential pro-hapten chemical sensitizers using a cysteine-based synthetic peptide (Gerberick et al., 2009) . The incorporation of lysine as another relevant nucleophile in this model will allow for a more comprehensive assessment of chemical reactivity for screening purposes and expands the portfolio of reactivity-based alternatives for skin sensitization testing.
In this present study, 70 allergens and nonallergens of diverse chemical structure and sensitization potency (weakextreme) were assessed for direct and HRP/P-mediated reactivity with cysteine and lysine using a concentrationresponse study design. The chemicals cover a variety of reaction mechanistic domains and include 26 haptens that comprised acyl transfer agents, Schiff base formers, Michael acceptors, and S N 2 electrophiles (Roberts et al., 2007) . Peptide reactivity, expressed in terms of EC15, is an estimate of the test chemical concentration that depletes the peptide by 15% under the conditions described. EC15 was estimated by fitting a three-parameter log-logistic model to peptide depletion data using RExcel. If peptide depletion did not exceed 10% for cysteine without HRP/P, 40% for cysteine with HRP/P, and > 15% for lysine with or without HRP/P, reactivity was reported as NC (not calculated). If peptide depletion exceeded a threshold value (above) but was generally low or insufficient for estimating the EC15, reactivity was designated as NR (not reported). Nonsensitizers that were NC for cysteine and lysine ± HRP/P were excluded from this table. N/A, not applicable. 
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The chemical set also includes 19 pro-haptens and prehaptens for evaluating the use of a HRP/P oxidation system for activating nonelectrophilic chemical sensitizers. In comparison to direct reactivity measurements, coincubation of HRP/P with pre-/pro-haptens and cysteine resulted in significant peptide depletion that was typically observed at lower concentrations. Nonenzymatic (direct) reactivity for pre-hapten sensitizers generally resulted in similar depletion profiles compared to those with HRP/P. The activation of exclusively lysine-reactive pro-haptens with HRP/P has not been demonstrated in the present study. Although the majority of pre-/pro-haptens were reactive with cysteine, additional testing with a more representative set of pro-haptens is needed to judge whether reactions with lysine in the presence of HRP/P is required for standard testing. For testing unknowns, the most conservative approach is including lysine þ HRP/P which may identify potential lysine-selective pro-haptens.
By comparing the extent of reactivity between nonsensitizers and sensitizers, threshold positive depletion values were determined to examine the potential use of this model for basic hazard assessments. Peptide depletion for the majority of nonsensitizers was generally < 10% for cysteine and < 15% for lysine. In the presence of HRP/P, however, cysteine depletion for a few nonsensitizers was > 10%. By comparison, cysteine depletion for pre-/pro-haptens with HRP/P was typically ! 40%. Based on these observations, threshold positive depletion values were identified empirically for any reaction with > 10 or > 40% for cysteine in the absence and presence of HRP/P, respectively, or > 15% for lysine with or without HRP/P. A prediction accuracy of 83% was demonstrated for the 70 chemicals examined in this study. Although slightly lower than the 89% accuracy reported previously for the DPRA , the chemical set used to evaluate the DPRA prediction model was essentially devoid of pre-/pro-haptens. In this study, 42 of the 45 sensitizers were identified correctly. Nine of the 12 misclassifications were false positives and 3 were false negatives. The high sensitivity (93%) is encouraging for a provisional model that included 19 pre-/pro-haptens and 26 haptens. In addition, the relatively low specificity (64%) highlights further the need for additional test information (i.e., skin penetration) to potentially reduce the number of false positives expected from weakly reactive nonsensitizers (i.e., methyl paraben, propyl paraben, and their hydrolysis reaction product 4-hydroxybenzoic acid). The weak pro-haptens aniline and cinnamic alcohol were activated in the presence of HRP/P but cysteine depletion did not exceed the empirical threshold positive value for this reaction (i.e., > 40%).
General trends in peptide depletion appear to coincide well with skin sensitization potential (Tables 2 and 3 ). In contrast to the majority of nonsensitizers that showed little to no peptide reactivity, the majority of sensitizers, including haptens and pre-/pro-haptens, demonstrated substantial reactivity. Weak sensitizers were distinguished from moderate, strong, and extreme sensitizers by exhibiting no measurable depletion ( 10%) at concentrations < 3mM. Moderate, strong, and extreme haptens were generally distinguished from weak haptens by higher depletion values. In addition, the majority of moderate, strong, and extreme sensitizers were reactive toward both cysteine and lysine nucleophiles. Moreover, Figure 4 shows the median EC15 value for moderate and strong/extreme sensitizers were lower than those observed for weak and nonsensitizers.
One advantage with including lysine in reactivity assessments is to identify sensitizers that are selective to e-NH 2 groups. In this study, four sensitizers showed selective reactivity toward lysine including two strong/extreme (hexaphthalic anhydride, phenyl isocyanate) and two weak sensitizers (7-hydroxycitronellal and 4-methylundecanal). Glyoxal and 2-hydroxyethyl acrylate, both moderate sensitizers, exhibited high depletion of cysteine at relatively low concentrations (i.e., 0.03 or 3mM), whereas depletion of lysine, although extensive (> 50%), was only observed at the 30mM concentration. In addition, seven sensitizers were identified as having higher reactivity toward lysine compared with cysteine. In contrast, 11 sensitizers were exclusively reactive toward cysteine peptide and nearly all of them were pre-/pro-haptens. The majority of sensitizing chemicals examined (27/45) were reactive toward both cysteine and lysine peptides. Although oxazolone, 3,4-dihydrocoumarin, and farnesal were slightly reactive to cysteine, higher depletion was observed with lysine and the depletion profiles were amenable for determining an EC15 values.
Trends in reactivity for weak allergens examined in this study were less consistent than moderate, strong, and extremes, demonstrating further the need for considering other variables (e.g., bioavailability, dendritic cell activation) for accurate predictions of skin sensitization potency. In general, however, negligible loss of peptide was typically observed at concentrations 3mM for at least one nucleophile. It is interesting to note that moderate sensitizers were generally more reactive than structural analogs that are classified as weak or nonallergens and less reactive than strong/extremes (i.e., cinnamaldehyde, acrylates, coumarins, dialdehydes/diketones).
For the terpene aldehydes (7-hydroxycitronellal, citral, and farnesal), reactivity toward cysteine was typically low and lacked a concentration-response. Depletion of lysine, however, was ! 30% but only at the highest concentration tested (i.e., 30mM). Because the reactive species for these materials may be attributed to hydroperoxide formation via auto-oxidation in storage, the observed depletion might be due to reactivity of low-level hydroperoxide degradants. One issue for in chemico assays is test chemical solubility, particularly in reactions with lipophilic molecules that are performed with a low organic content (Merckel et al., 2010) . The use of microemulsions has been shown recently to overcome compatibility problems with 7-hydroxycitronellal and citral reactivity toward glutathione (GSH) (Merckel et al., 2010) . These materials were reactive to 434 the thiol group of GSH, and for 7-hydroxycitronellal, secondary reactions at the a-NH 2 group to form a cyclic hemithioacetal structure was observed (Merckel et al., 2010) . Although lysine and cysteine reactions reported here are performed in separate incubations, these findings suggest the potential for reactivity of these materials to nucleophiles which contain -SH and -NH 2 groups.
The target test chemical concentration range selected in this study (i.e., 0.003-30mM) was based on preliminary studies that indicated higher concentrations of chemical were needed for detecting reactivity with lysine or chemicals that are weakly reactive toward cysteine. Although the final organic content is low (i.e., 1%), the procedure for selecting a compatible solvent begins with solubility testing in various solvents prior to performing the actual experiment. One potential limitation of the assay is limited or unknown aqueous solubility of the test chemical. Despite the potential solubility issues for certain chemicals, this may be overcome by reducing the final test chemical concentration or increasing the amount of co-solvent to ensure that the test chemical is fully soluble. The primary reason for reducing the % organic in the PPRA is to minimize the potential for reduced HRP-mediated activation via inhibition and/or protein denaturation. This has not been examined experimentally with HRP but significant solvent effects have been demonstrated for P450-mediated metabolism studies with small organic molecules. Another potential challenge is selecting an appropriate test chemical concentration for unknowns; thus, repeat experiments may be needed to adjust the concentration to an optimal range.
Although peptide reactivity is an important criterion for evaluating the potential of novel materials to initiate skin sensitization, it is not expected to correlate completely with skin sensitization potency as defined by existing animal and human data. Skin penetration, dendritic cell activation, and immune recognition by T cells should also be considered for a more holistic assessment of skin sensitization potential. For routine screening purposes during early product development, however, the prospective use of peptide reactivity data may involve comparisons of reactivity profiles between novel materials and structural analogs that are known sensitizers. In this way, it may be useful to examine the data set between structural analogs to correlate peptide reactivity to skin sensitization potency. For example, 6-methylcoumarin and coumarin, both nonsensitizers, exhibited little to no reactivity toward lysine or cysteine, whereas reactivity of 3,4-dihydrocoumarin toward lysine was substantial and showed a clear concentration-response. Similarly, direct (ÀHRP/P) lysine depletion at the 30mM test chemical concentration was equally extensive for moderate and strong dialdehyde/diketone and acrylate sensitizers in comparison to weak sensitizing analogs which appeared to exhibit similar reactivity profiles toward cysteine.
In summary, reactivity data presented here highlight the utility for testing lysine as a relevant nucleophile for screening contact allergens. The majority of sensitizers examined (27 of 45) were lysine reactive and four showed preferential reactivity toward this nucleophile. Characterizing the potential for chemicalinduced modification of lysine residues in chemico could contribute significantly to the development of integrated testing strategies in the near-term and reduce the number of false negatives with sensitizers that are exclusively reactive to -NH 2 groups in proteins. An assessment of the amino acid composition in pigskin revealed that the amount of lysine is greater than 10-fold higher than cysteine and nearly 3-fold higher than histidine (Nguyen et al., 1986) . Changes in protein structure at lysine and cysteine residues may create new epitopes and increase the risk in immunogenicity for contact allergens. Reactivity to lysine may also be relevant for chemicals that are highly reactive to cysteine, which may result in a decrease in the antioxidant protection via glutathione depletion in vivo. Similar to the LLNA, the approach involves the generation of concentrationresponse data such that an estimate of the relative reactivity potency can be made based on the concentration of test chemical that depletes peptide at or above a threshold positive value. Here, we report the use of EC15 as one example to illustrate the use of the model as a screening approach for assessing the peptide reactivity potential of novel chemicals. Quantifying reactivity based on concentration rather than % depletion may be useful for extrapolating in chemico data to the in vivo situation and may involve the use of modeling approaches for internal dosimetry determinations. In this way, basic hazard information from nonanimal models can be integrated for comparison to human exposure data for quantitative risk assessments.
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